Not applicableAvailableNCT07215832What this trial is testingKaryopharm Expanded Access Program for SelinexorWho this might be right forMultiple MyelomaDiffuse Large B-Cell Lymphoma (DLBCL)Sarcoma+5 more Karyopharm Therapeutics Inc